Pure & Natural for eco-fashion
This article was originally published in The Rose Sheet
Executive Summary
Naturals-inspired personal care brand Pure & Natural will sponsor Future Fashion, an eco-friendly runway show, in anticipation of its February launch in mass doors, the brand announces Jan. 25. The show on Jan. 31 kicks off New York Fashion Week with a display of creations by top-shelf designers including Burberry, Derek Lam, Diane Von Furstenberg, Versace, Michael Kors, and others. Future Fashion is "geared toward raising awareness about the need to use sustainable materials in the fashion industry," Pure & Natural says. Brand offers "eco-conscious" body wash, liquid hand soap and bar soap, all formulated with natural ingredients and packaged in recycled materials (1"The Rose Sheet" Oct. 1, 2007, In Brief)...
You may also be interested in...
Marketing In Brief
Coty Prestige: A new Chloe scent for women - the first since Coty acquired Unilever Prestige two years ago - will debut on counters in February 2008, according to Sept. 25 release (1"The Rose Sheet" July 18, 2005, p. 8). The fragrance will launch simultaneously in Europe, the U.S., Canada, Southeast Asia, Japan, the Middle East and Australia. "This new women's fragrance reflects the values of the Chloe brand: a contemporary vision of femininity, both aspirational and universal," Michele Scannavini, Coty Prestige president, remarks. Company stresses the importance of the Chloe acquisition in its development, noting that Coty "now holds the leading position on the worldwide fragrance market. The new scent follows Chloe Collection, which bowed in 2005...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.